Observing antibiotic use in children with pneumonia
Official title: Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia: a Prospective, Observational Study
Run by ARCIM Institute Academic Research in Complementary and Integrative Medicine · NCT04681339 · Data updated 2026-11-12
This study looks at how often children with pneumonia in the hospital are given antibiotics and how parents feel about their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 3 Months to 18 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | ARCIM Institute Academic Research in Complementary and Integrative Medicine Academic / other |
| Locations | 2 sites (Filderstadt, Baden-Wurttemberg and 1 other locations) |
| Status | Recruiting |
| Started | September 16, 2022 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | September 17, 2026 |
| Trial ID | NCT04681339 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children hospitalized for pneumonia at the participating pediatric departments.
✕Probably not a fit
Patients who do not have pneumonia or those who are not admitted to the specified hospitals may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to document the rate of antibiotic prescriptions in children hospitalized for community-acquired pneumonia at a pediatric department known for its restrictive antibiotic prescribing practices. It will assess how physicians make decisions regarding antibiotic use and will also evaluate parental satisfaction with the treatment process. Data will be collected on the severity of the disease, medical complications, and the frequency of factors influencing antibiotic decisions. Parents will be contacted four weeks post-discharge to gather information on any recurrence or readmission.
Why it matters
Potential benefit: If successful, this study could improve antibiotic stewardship practices and enhance treatment outcomes for children with pneumonia.
How similar studies have gone: Other studies have shown success in improving antibiotic prescribing practices through observational approaches, indicating that this methodology is both relevant and tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hospital admission at the pediatric department of the Filderklinik or at the pediatric department of the Herdecke Community Hospital * Admission diagnosis pneumonia or pneumonia diagnosis within 48 hours of admission * Written informed consent by care giver * All inclusion criteria have to be fulfilled Exclusion Criteria: * Insufficient knowledge of German to understand the written patient information and questionnaire
Where it's running
-
Die Filderklinik
Filderstadt, Baden-Wurttemberg, Germany Recruiting -
Herdecke Community Hospital
Herdecke, North Rhine-Westphalia, Germany Recruiting
Study contacts
- Principal investigator: Jan Vagedes, Dr — Arcim Institute
- Study coordinator: Jan Vagedes, Dr
- Email: j.vagedes@arcim-institute.de
- Phone: +49 711 7703
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lung ultrasound to guide antibiotic decisions in children with pneumonia
This will see if using lung ultrasound for children aged 3–10 with suspected pneumonia leads to fewer antibiotic prescriptions than usual care.
-
Reducing vancomycin use in newborn intensive care
This trial tests whether giving outside support to Level III NICUs helps staff follow vancomycin-reduction practices for newborns at risk of late-onset sepsis.
-
Comparing 5-day versus standard antibiotic treatment for pneumonia in children
This study is testing if a shorter 5-day course of antibiotics is just as effective as the usual 7-14 day treatment for pneumonia in kids aged 3 months to 18 years.
-
Comparing a placebo to an antibiotic for pneumonia in children
This study is testing if an antibiotic called azithromycin helps children aged 3-17 with pneumonia caused by Mycoplasma pneumoniae get better faster than a placebo.
-
Evaluating antibiotic use before onabotulinumtoxinA injections for overactive bladder
This study is testing if giving antibiotics before onabotulinumtoxinA injections helps or is needed for adults with overactive bladder who haven't found relief from other treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.